Characterisation of chromatin modifiers in endometrial cancer

Characterisation of chromatin modifiers in endometrial cancer

<p>Chromatin organization is a critical regulator of gene expression and cell phenotype, and is frequently dysregulated in cancer. Endometrial cancer (EC) is the most common gynecological malignancy, and casues significant morbidity and mortality. EC is notable for recurrent alterations in chr...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Kedzierska, KZ
Altri autori:	Church, D
Natura:	Tesi
Lingua:	English
Pubblicazione:	2024
Soggetti:	Cancer

Documenti analoghi

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
di: Dore M, et al.
Pubblicazione: (2021-10-01)

Prognostic Significance of Dysregulated Epigenomic and Chromatin Modifiers in Cervical Cancer
di: Aswathy Mary Paul, et al.
Pubblicazione: (2021-10-01)

A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients
di: Zesi Liu, et al.
Pubblicazione: (2022-10-01)

Characterising ISWI chromatin remodeler in Trypanosoma cruzi
di: Yirys Díaz-Olmos, et al.

Druggable genetic targets in endometrial cancer✰,✰✰
di: Steven Lehrer, et al.
Pubblicazione: (2022-01-01)

The treatment of special types of endometrial cancer
di: Meng Zhang, et al.
Pubblicazione: (2022-08-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
di: An-Ju Chou, et al.
Pubblicazione: (2024-11-01)

Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread
di: Stephanie A. Sullivan, et al.
Pubblicazione: (2021-05-01)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
di: Hannah van der Woude, et al.
Pubblicazione: (2022-08-01)

How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
di: Brigida Anna Maiorano, et al.
Pubblicazione: (2022-04-01)

Chromatin structure in cancer
di: Meng Wang, et al.
Pubblicazione: (2022-07-01)

Robotics in Endometrial Cancer Care
di: Joseph Ng
Pubblicazione: (2013-11-01)

The modern management of endometrial cancer
di: Catherine M. Holland, et al.
Pubblicazione: (2011-12-01)

The modern management of endometrial cancer
di: Catherine M. Holland, et al.
Pubblicazione: (2011-12-01)

GENETIC ASPECTS OF ENDOMETRIAL CANCER
di: V. A. Pushkarev, et al.
Pubblicazione: (2014-09-01)

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
di: Sebastian Stępień, et al.
Pubblicazione: (2023-04-01)

Racioethnic Disparities in Endometrial Cancer Outcomes
di: Ojone Illah, et al.
Pubblicazione: (2024-02-01)

TRENDS OF ENDOMETRIAL CANCER IN CENTRAL INDIA: AN INSTITUTIONAL REVIEWTrends of Endometrial Cancer in Central India: An Institutional Review
di: Dhruv G Patel, et al.
Pubblicazione: (2020-06-01)

Management of inoperable endometrial cancer
di: Supakorn Pitakkarnkul, et al.
Pubblicazione: (2022-07-01)

The Roles of Endoscopy in Endometrial Cancer
di: Chyi-Long Lee, et al.
Pubblicazione: (2008-12-01)

PREDICTION ENDOMETRIAL CANCER IN WOMEN WITH ENDOMETRIAL HYPERPLASTIC PROCESSES IN PREMENOPAUSAL
di: A. L. Unanyan, et al.
Pubblicazione: (2016-09-01)

The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer
di: Jakub Dobroch, et al.
Pubblicazione: (2022-03-01)

KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer
di: Mi Han, et al.
Pubblicazione: (2020-01-01)

Assessment of Preoperative Endometrial Histopathological Sampling as a Predictor of Final Surgical Pathology in Endometrial Cancer
di: Mario Augusto Silveira Bueno Piotto, et al.

Telomeres and telomerase in endometrial cancer and hyperplasia
di: Anna Pańczyszyn, et al.
Pubblicazione: (2024-03-01)

Epidemiology of Endometrial Cancer in North of Iran
di: Shahla Yazdani, et al.
Pubblicazione: (2017-01-01)

The significance of markers in the diagnosis of endometrial cancer
di: Monika M. Żyła, et al.
Pubblicazione: (2016-11-01)

Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
di: Amritha Sreekumar, et al.
Pubblicazione: (2023-01-01)

Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses
di: Song YJ, et al.
Pubblicazione: (2023-10-01)

Accuracy of Pre-operative Endometrial Sampling for the Detection of High Grade Endometrial Cancer
di: Uraiwan Khomphaiboonkij, et al.
Pubblicazione: (2015-09-01)

Telomerase and Telomeres in Endometrial Cancer
di: Rafah A. A. Alnafakh, et al.
Pubblicazione: (2019-05-01)

Comparison of Oncological and Surgical Outcomes of Robot-Assisted, Laparoscopic Modified Radical Hysterectomy and Laparotomy for Endometrial Cancer
di: Masako Ishikawa, et al.
Pubblicazione: (2024-02-01)

Chromatin and the DNA damage response: The cancer connection
di: Martijn S. Luijsterburg, et al.
Pubblicazione: (2011-08-01)

Psychometric validation of the Functional Assessment of Cancer Therapy‐Endometrial among endometrial cancer patients
di: Sooyeon Kim, et al.
Pubblicazione: (2024-03-01)

Model Predicting the Risk of Endometrial Hyperplasia Developing into Endometrial Cancer
di: Su J, et al.
Pubblicazione: (2024-09-01)

SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER
di: A. I. Berishvili, et al.
Pubblicazione: (2017-06-01)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
di: Haley A. Moss, et al.
Pubblicazione: (2014-12-01)

Axin2+ endometrial stem cells: the source of endometrial regeneration and cancer
di: Shafiq M. Syed, et al.
Pubblicazione: (2020-05-01)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
di: Dan Kuai, et al.
Pubblicazione: (2023-07-01)

A multiomics comparison between endometrial cancer and serous ovarian cancer
di: Hui Zhong, et al.
Pubblicazione: (2020-01-01)